Opinion

» funding and genetics & genomics

Most Recent

image: Opinion: GMOs Are Not “Frankenfoods”

Opinion: GMOs Are Not “Frankenfoods”

By and | August 30, 2016

It behooves the scientific community to reflect on the public’s “Franken-” characterization of genetically modified foods.

9 Comments

image: Opinion: Engineering the Epigenome

Opinion: Engineering the Epigenome

By , and | August 26, 2015

The use of targetable chromatin modifiers has ushered in a new era of functional epigenomics.

1 Comment

image: Opinion: Share Diverse Genomic Data

Opinion: Share Diverse Genomic Data

By | August 12, 2015

Personalized interpretation is the next frontier in clinical genomics, but we won’t get there without sharing data representing all ethnic groups.

0 Comments

image: Opinion: Too Many Mitochondrial Genome Papers

Opinion: Too Many Mitochondrial Genome Papers

By | June 29, 2015

And too few insights gleaned from them

4 Comments

image: Opinion: <em>Star Trek</em> Medicine

Opinion: Star Trek Medicine

By | November 6, 2014

An apology for basic research

2 Comments

image: Opinion: #IceBucketChallenge, Investing Well

Opinion: #IceBucketChallenge, Investing Well

By | September 10, 2014

Hundreds of thousands participated in the ALS campaign that went viral, but how are they supposed to decide where to donate?

3 Comments

image: Opinion: Bioinformatics Software: A Buyer’s Guide

Opinion: Bioinformatics Software: A Buyer’s Guide

By | September 2, 2014

How to choose programs that suit your lab’s ’omics analysis needs

0 Comments

image: Opinion: GM Salmon: Just the Beginning

Opinion: GM Salmon: Just the Beginning

By | June 1, 2014

Sound risk management concerning genetically engineered food animals is critical. 

2 Comments

image: Opinion: Sizing Up GM Salmon

Opinion: Sizing Up GM Salmon

By | June 1, 2014

On the potential benefits and risks of genetically modified fish entering the marketplace 

0 Comments

image: Opinion: Overcoming Cancer’s Complexities

Opinion: Overcoming Cancer’s Complexities

By , and | April 11, 2014

Considering “targeted therapeutics” in the face of intra-patient heterogeneity. 

2 Comments

Popular Now

  1. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  2. Sequencing Reveals Genomic Diversity of the Human Brain
  3. How Plants Evolved Different Ways to Make Caffeine
  4. What Sensory Receptors Do Outside of Sense Organs
RayBiotech